283 related articles for article (PubMed ID: 28148900)
1. Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.
Wang M; Zhang S; Chuang SS; Ashton-Key M; Ochoa E; Bolli N; Vassiliou G; Gao Z; Du MQ
Oncotarget; 2017 Mar; 8(11):17763-17770. PubMed ID: 28148900
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL.
Nguyen PN; Tran NTB; Nguyen TPX; Ngo TNM; Lai DV; Deel CD; Hassell LA; Vuong HG
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):431-438. PubMed ID: 33849798
[TBL] [Abstract][Full Text] [Related]
3. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
4. Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma.
Fukumoto K; Nguyen TB; Chiba S; Sakata-Yanagimoto M
Cancer Sci; 2018 Mar; 109(3):490-496. PubMed ID: 28889481
[TBL] [Abstract][Full Text] [Related]
5. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
Sakata-Yanagimoto M; Enami T; Yoshida K; Shiraishi Y; Ishii R; Miyake Y; Muto H; Tsuyama N; Sato-Otsubo A; Okuno Y; Sakata S; Kamada Y; Nakamoto-Matsubara R; Tran NB; Izutsu K; Sato Y; Ohta Y; Furuta J; Shimizu S; Komeno T; Sato Y; Ito T; Noguchi M; Noguchi E; Sanada M; Chiba K; Tanaka H; Suzukawa K; Nanmoku T; Hasegawa Y; Nureki O; Miyano S; Nakamura N; Takeuchi K; Ogawa S; Chiba S
Nat Genet; 2014 Feb; 46(2):171-5. PubMed ID: 24413737
[TBL] [Abstract][Full Text] [Related]
6. Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis.
Attygalle AD; Dobson R; Chak PK; Vroobel KM; Wren D; Mugalaasi H; Morgan Y; Kaur M; Ahmad R; Chen Z; Naresh KN; Du MQ
Histopathology; 2022 Apr; 80(5):847-858. PubMed ID: 35064935
[TBL] [Abstract][Full Text] [Related]
7. DNMT3A
Zheng J; Wang Z; Pan X; Zhang Z; Li H; Deng X; Liu P; Zhang Q; Na F; Chen C; Niu T; Liu Y
Oncogene; 2023 Jun; 42(23):1940-1950. PubMed ID: 37127775
[TBL] [Abstract][Full Text] [Related]
8. IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
Leca J; Lemonnier F; Meydan C; Foox J; El Ghamrasni S; Mboumba DL; Duncan GS; Fortin J; Sakamoto T; Tobin C; Hodgson K; Haight J; Smith LK; Elia AJ; Butler D; Berger T; de Leval L; Mason CE; Melnick A; Gaulard P; Mak TW
Cancer Cell; 2023 Feb; 41(2):323-339.e10. PubMed ID: 36736318
[TBL] [Abstract][Full Text] [Related]
9. Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.
Dobay MP; Lemonnier F; Missiaglia E; Bastard C; Vallois D; Jais JP; Scourzic L; Dupuy A; Fataccioli V; Pujals A; Parrens M; Le Bras F; Rousset T; Picquenot JM; Martin N; Haioun C; Delarue R; Bernard OA; Delorenzi M; de Leval L; Gaulard P
Haematologica; 2017 Apr; 102(4):e148-e151. PubMed ID: 28082343
[No Abstract] [Full Text] [Related]
10. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.
Butzmann A; Sridhar K; Jangam D; Kumar J; Sahoo MK; Shahmarvand N; Warnke R; Rangasamy E; Pinsky BA; Ohgami RS
Int J Mol Med; 2020 Oct; 46(4):1466-1476. PubMed ID: 32945366
[TBL] [Abstract][Full Text] [Related]
11. Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma.
Sakata-Yanagimoto M; Nakamoto-Matsubara R; Komori D; Nguyen TB; Hattori K; Nanmoku T; Kato T; Kurita N; Yokoyama Y; Obara N; Hasegawa Y; Shinagawa A; Chiba S
Ann Hematol; 2017 Sep; 96(9):1471-1475. PubMed ID: 28634614
[TBL] [Abstract][Full Text] [Related]
12. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.
Wang C; McKeithan TW; Gong Q; Zhang W; Bouska A; Rosenwald A; Gascoyne RD; Wu X; Wang J; Muhammad Z; Jiang B; Rohr J; Cannon A; Steidl C; Fu K; Li Y; Hung S; Weisenburger DD; Greiner TC; Smith L; Ott G; Rogan EG; Staudt LM; Vose J; Iqbal J; Chan WC
Blood; 2015 Oct; 126(15):1741-52. PubMed ID: 26268241
[TBL] [Abstract][Full Text] [Related]
13. TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma.
Schwartz FH; Cai Q; Fellmann E; Hartmann S; Mäyränpää MI; Karjalainen-Lindsberg ML; Sundström C; Scholtysik R; Hansmann ML; Küppers R
J Pathol; 2017 Jun; 242(2):129-133. PubMed ID: 28337768
[TBL] [Abstract][Full Text] [Related]
14. The curious origins of angioimmunoblastic T-cell lymphoma.
Cortés JR; Palomero T
Curr Opin Hematol; 2016 Jul; 23(4):434-43. PubMed ID: 27177312
[TBL] [Abstract][Full Text] [Related]
15. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2
Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L
Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970
[TBL] [Abstract][Full Text] [Related]
16. BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.
Nishizawa S; Sakata-Yanagimoto M; Hattori K; Muto H; Nguyen T; Izutsu K; Yoshida K; Ogawa S; Nakamura N; Chiba S
Int J Hematol; 2017 Apr; 105(4):465-469. PubMed ID: 27921272
[TBL] [Abstract][Full Text] [Related]
17. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
[TBL] [Abstract][Full Text] [Related]
18. RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis.
Cortes JR; Ambesi-Impiombato A; Couronné L; Quinn SA; Kim CS; da Silva Almeida AC; West Z; Belver L; Martin MS; Scourzic L; Bhagat G; Bernard OA; Ferrando AA; Palomero T
Cancer Cell; 2018 Feb; 33(2):259-273.e7. PubMed ID: 29398449
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections.
Nagao R; Kikuti YY; Carreras J; Kikuchi T; Miyaoka M; Matsushita H; Kojima M; Ando K; Sakata-Yanagimoto M; Chiba S; Nakamura N
Am J Surg Pathol; 2016 Aug; 40(8):1041-50. PubMed ID: 27158755
[TBL] [Abstract][Full Text] [Related]
20. Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma.
Nguyen TB; Sakata-Yanagimoto M; Fujisawa M; Nuhat ST; Miyoshi H; Nannya Y; Hashimoto K; Fukumoto K; Bernard OA; Kiyoki Y; Ishitsuka K; Momose H; Sukegawa S; Shinagawa A; Suyama T; Sato Y; Nishikii H; Obara N; Kusakabe M; Yanagimoto S; Ogawa S; Ohshima K; Chiba S
Cancer Res; 2020 May; 80(9):1875-1884. PubMed ID: 32107212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
